Endocrinology
Conference Coverage
For COVID-19 plus diabetes, glycemic control tops treatment list
Tight glucose control led to better results in patients with diabetes and COVID-19.
Conference Coverage
Diabetes hospitalizations halved with FreeStyle Libre glucose monitor
Hospitalizations for diabetic ketoacidosis, diabetes-related emergencies, and all-cause hospitalizations were reduced following initiation of...
Conference Coverage
Half of young adults with diabetes have diastolic dysfunction
Measures of diastolic dysfunction, a heart failure precursor, from tissue Doppler echo showed high prevalence rates in young patients with...
Conference Coverage
EMPA-REG OUTCOME: Empagliflozin cut insulin need in type 2 diabetes
Post-hoc analysis from EMPA-REG OUTCOME showed that type 2 diabetes patients who received empagliflozin had less need for insulin than controls....
From the Journals
Half of type 1 diabetes patients with COVID-19 manage at home
Despite high rates of hyperglycemia and DKA, only about half of patients with type 1 diabetes and COVID-19 required hospitalization, according to...
News
FDA recalls extended-release metformin due to NDMA impurities
From the Journals
‘The story unfolding is worrisome’ for diabetes and COVID-19
Diabetes Care has published a host of new articles on diabetes and COVID-19 infection, as NIDDK researchers also acknowledge risks to other organ...
From the Journals
COVID-19 may cause subacute thyroiditis
From the Journals
Glucose control linked to COVID-19 outcomes in largest-yet study
Wuhan researchers found preexisting type 2 diabetes worsened prognosis of COVID-19; but those whose glucose stayed “in-range” had better outcomes...
News
Societies offer advice on treating osteoporosis patients during pandemic
General and specific recommendations from leading bone health organizations shine a light on how to manage osteoporosis patients during the COVID-...
News
FDA approves dapagliflozin for low-EF heart failure